Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 5, 2008, Pages 548-553

  Huang, Chin Wei ^a   Pai, Ming Chyi ^a   Tsai, Jing Jane ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anti epileptic drug; Cognition; Intractable epilepsy; Levetiracetam; Topiramate

Indexed keywords

ETIRACETAM; TOPIRAMATE;

ADD ON THERAPY; ADULT; ANXIETY; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFECT; FEMALE; HUMAN; INTRACTABLE EPILEPSY; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; SIDE EFFECT; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTICONVULSANTS; COGNITION DISORDERS; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; EPILEPSY, COMPLEX PARTIAL; EPILEPSY, TONIC-CLONIC; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PIRACETAM; PROSPECTIVE STUDIES; PSYCHOMETRICS; TAIWAN; YOUNG ADULT;

EID: 53149107138     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01848.x     Document Type: Article

References (34)

1. Schmidt D, Loscher W. Drug resistance in epilepsy: Putative neurobiologic and clinical mechanism. Epilepsia 2005 46 : 858 877.
2. Regesta G, Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res. 1999 34 : 109 122.
3. Cavazos JE, Cross DJ. The role of synaptic reorganization in mesial temporal lobe epilepsy. Epilepsy Behav. 2006 8 : 483 493.
4. Brunbech L, Sabers A. Effect of antiepileptic drugs on cognitive function in individuals with epilepsy. Drugs 2002 62 : 593 604.
5. Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003 44 : S21 S29.
6. Cramer JA, Fisher R, Ben-Menachem E, French J, Mattson RH. New antiepileptic drugs: Comparison of key clinical trials. Epilepsia 1999 40 : 590 600.
7. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: A summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res. 2007 73 : 1 52.
8. Shannon HE, Love PL. Effects of antiepileptic drugs on learning as assessed by a repeated acquisition of response sequences task in rats. Epilepsy Behav. 2007 10 : 16 25.
9. Martin R, Kuzniecky R, Ho S et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999 52 : 321 327.
10. Aldenkamp AP, Baker G, Mulder OG et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000 41 : 1167 1178.
11. Lee S, Sziklas V, Andermann F et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 2003 44 : 339 347.
12. Lynch BA, Lambeng N, Nocka K et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl Acad. Sci. USA 2004 101 : 9861 9866.
13. Piazzini A, Chifari R, Canevini MP, Turner K, Fontana SP, Canger R. Levetiracetam: An improvement of attention and of oral fluency in patients with partial epilepsy. Epilepsy Res. 2006 68 : 181 188.
14. Lamberty Y, Margineanu DG, Klitgaard H. Absence of negative impact of levetiracetam on cognitive function and memory in normal and amygdala-kindled rats. Epilepsy Behav. 2000 1 : 333 342.
15. Aldenkamp AP, Wieringen AV, Alpherts WCJ et al. Double blind placebo controlled neuropsychological and neurophysiological investigations with oxiracetam (CGP 21690E) in memory impaired patients with epilepsy. Neuropsychobiology 1990 24 : 90 101.
16. Hock FJ. Drug influences on learning and memory in aged animals and humans. Neuropsychobiology 1987 17 : 145 160.
17. Bootsma HP, Aldenkamp AP, Diepman L et al. The effect of antiepileptic drugs on cognition: Patient perceived cognitive problems of topiramate versus levetiracetam in clinical practice. Epilepsia 2006 47 : S24 S27.
18. Berg AT. Defining intractable epilepsy. Adv. Neurol. 2006 97 : 5 10.
19. Tsai JJ, Yen DJ, Hsih MS et al. Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: A multicenter, randomized, double-blind, placebo-controlled study. Epilepsia 2006 47 : 72 81.
20. Teng EL, Hasegawa K, Homma A et al. The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. Int. Psychogeriatr. 1994 6 : 45 58.
21. White L, Petrovitch H, Ross GW et al. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA 1996 276 : 955 960.
22. Huang CW, Hsieh YJ, Tsai JJ, Pai MC. Cognitive performance in cryptogenic epilepsy. Acta Neurol. Scand. 2005 112 : 228 233.
23. Lee HW, Jung DK, Suh CK, Kwon SH, Park SP. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up. Epilepsy Behav. 2006 8 : 736 741.
24. Gomer B, Wagner K, Frings L et al. The influence of antiepileptic drugs on cognition: A comparison of levetiracetam with topiramate. Epilepsy Behav. 2007 10 : 486 494.
25. Wu SP, Tsai JJ, Gean PW. Frequency-dependent inhibition of neuronal activity by topiramate in rat hippocampal slices. Br. J. Pharmacol. 1998 125 : 826 832.
26. Shank RP, Gardocki JF, Vaught JL et al. Topiramate: Preclinical evaluation of structurally novel anticonvulsant. Epilepsia 1994 35 : 450 460.
27. Pai MC, Tsai JJ. Is cognitive reserve applicable to epilepsy? The effect of educational level on the cognitive decline after onset of epilepsy. Epilepsia 2005 46 : S7 S10.
28. Johnson BA, Roache JD, Ait-Daoud N et al. Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007 31 : 123 130.
29. Backstrom P, Hyytia P. Attenuation of cocaine-seeking behaviour by the AMPA/kainate receptor antagonist CNQX in rats. Psychopharmacology (Berl) 2003 166 : 69 76.
30. Kudin AP, Debska-Vielhaber G, Vielhaber S, Elger CE. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 2004 45 : 1478 1487.
31. Lathers CM, Schraeder PL, Claycamp HG. Clinical pharmacology of topiramate versus lamotrigine versus phenobarbital: Comparison of efficacy and side effects using odds ratios. J. Clin. Pharmacol. 2003 43 : 491 503.
32. Gilliam FG, Veloso F, Bomhof MA et al. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 2003 60 : 196 202.
33. Giurgea CE, Greindl MG, Preat S. Nootropic drugs and aging. Acta Psychiatr. Belg. 1983 83 : 349 358.
34. Custer KL, Austin NS, Sullivan JM, Bajjalieh SM. Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J. Neurosci. 2006 26 : 1303 1313.